Some medical devices exempted from China tariffs
Aktueller Standort:
> This Story

starstarstarstarstar (1)
Log in oder Register to rate this News Story
Forward Printable StoryPrint Comment




Business Affairs Homepage

Siemens to acquire Corindus Vascular Robotics in $1.1 billion deal Royal currently has a 12.8 percent stake in Corindus

RadNet acquires Nulogix, opens new AI division Will develop applications for image interpretation

Health Catalyst IPO — The Signify View The industry analysts share their perspective on the announcement

Carestream completes sale of IT business to Philips in most countries Now part of Philips in 26 of 38 countries where it operates

Siemens diagnostics president to step down, new board member appointed CEO Bernd Montag will assume responsibility of the business unit

Siemens rises above $4 billion in revenue in third quarter Revenue rose by 5.8 percent compared to last year

Four tips to creating greater efficiencies in your imaging department Insights from the data obtained by Definitive Healthcare

Hospital M&A revenue rose to $11.3 billion in Q2 this year Atrium Health acquiring Wake Forest Baptist Health was most notable

Philips Q2 sales helped by Chinese healthcare spending Sales rose in the U.S. and Europe as well

UnitedHealth Group reported strong second quarter 2019 results, beating expectations Total revenues at $60.6 billion, up eight percent year over year

Some medical devices exempted from China tariffs

by Thomas Dworetzky , Contributing Reporter
Last week, the Trump administration announced it would exempt 110 Chinese products, including some medical equipment, from its 25 percent tariffs placed on $34 billion of Chinese imports on July 6, 2018.

The exclusions are retroactive to that date, according to Reuters, and will be in place for a year from last Tuesday.

Story Continues Below Advertisement


Special-Pricing Available on Medical Displays, Patient Monitors, Recorders, Printers, Media, Ultrasound Machines, and Cameras.This includes Top Brands such as SONY, BARCO, NDS, NEC, LG, EDAN, EIZO, ELO, FSN, PANASONIC, MITSUBISHI, OLYMPUS, & WIDE.

The U.S. has levied tariffs on $250 billion on imports from China and now threatens to tax another $300 billion.

There were 12 exclusion requests granted to Medtronic, including one for a component in a device used to treat liver tumors.

Varian Medical Systems also received an exclusion for some of its equipment after claiming that that the tariffs would only hurt their firm, as there are no other “good alternatives,” noted Reuters, and that it would hurt it against European competitors.

Other device components that have been exempted include “veterinary ultrasound devices, certain parts and accessories of electro-surgical instruments, and dental X-ray alignment and positioning apparatuses,” according to a report in Medtech Dive.

But according to a June statement to USTR by the Advanced Medical Technology (AdvaMed) Association, which represents over 400 medical device makers, many devices that the group hoped would be exempted, including pacemakers, remain subject to the 25 percent tariff.

“If tit-for-tat retaliation continues, the administration’s objectives for a strong domestic medical technology industry will be undermined. We ask the administration to consider this adverse impact and to remove all medical technology products from its retaliation lists,” it stated.

In addition, it urged that, “including medical technology products on the USTR list is troubling from a public health perspective. Healthcare products have been consistently recognized as being exempt from trade sanctions — even with countries which the United States considers to be security risks.”

An ongoing trade war could threaten the 30 percent market share U.S. makers enjoy in China, AdvaMed noted.

“Chinese patients will continue to have access to innovative medical technology, but from other sources," AdvaMed said in June. "China will look for countries outside the United States — Europe, Japan, Southeast Asia — as alternative sources for U.S. technologies. AdvaMed and our members do not endorse imposing import tariffs on medical technology as a means of changing China’s behavior in our industry.”
  Pages: 1 - 2 >>

Business Affairs Homepage

You Must Be Logged In To Post A Comment